- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Dignitana Launches DigniCap Direct Partner Portal
Today Dignitana announces the launch of DigniCap Direct, a partner portal designed to provide added value to healthcare providers and facilitate the direct exchange of information between customers and the company. DigniCap Direct provides a streamlined process for healthcare providers to place orders and easily access DigniCap online training, clinical support, product information, and other account-specific documentation and resources.
“Dignitana already has a solid reputation for providing exemplary support and this new program takes that standard even higher with next level service, training, materials and best practices. Nurses and doctors are busy – they need instant access to information and this platform provides that link, as well as tools to increase the visibility and usage of DigniCap at their infusion center,” said Dignitana CEO Catarina Mård Löwenadler.
DigniCap Direct launched for US healthcare providers in September and distributors around the globe will be phased into the portal over the coming months.
“Demand for scalp cooling is growing quickly and we want to be sure that our partners have the resources needed at their fingertips to keep up with demand and provide DigniCap to as many patients as possible,” added Löwenadler.
For More Information Contact
Melissa Bourestom, Chief Communications Officer, email@example.com +1 469-518-5031
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB. Learn more at www.dignitana.com or www.dignicap.com.